• Intervacc’s Strangvac horse vaccine won New Zealand import clearance under a Special Circumstances Permit following a request from NZEHA.
• The permit enables an initial shipment of 1,200 vials despite Strangvac lacking local marketing authorization.
• Intervacc plans to seek full regulatory approval and registration for a future New Zealand launch.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Intervacc AB published the original content used to generate this news brief via Cision (Ref. ID: 20260728:BIT:2536:0) on July 29, 2026, and is solely responsible for the information contained therein.